FI73678C - Foerfarande foer framstaellning av farmaceutiskt anvaendbara azabicyklo-oktankarboxylsyror. - Google Patents

Foerfarande foer framstaellning av farmaceutiskt anvaendbara azabicyklo-oktankarboxylsyror. Download PDF

Info

Publication number
FI73678C
FI73678C FI813279A FI813279A FI73678C FI 73678 C FI73678 C FI 73678C FI 813279 A FI813279 A FI 813279A FI 813279 A FI813279 A FI 813279A FI 73678 C FI73678 C FI 73678C
Authority
FI
Finland
Prior art keywords
formula
group
hydrogen
eiler
acid
Prior art date
Application number
FI813279A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI73678B (fi
FI813279L (fi
Inventor
Michel Vincent
Georges Remond
Michel Laubie
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of FI813279L publication Critical patent/FI813279L/fi
Application granted granted Critical
Publication of FI73678B publication Critical patent/FI73678B/fi
Publication of FI73678C publication Critical patent/FI73678C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI813279A 1980-10-21 1981-10-20 Foerfarande foer framstaellning av farmaceutiskt anvaendbara azabicyklo-oktankarboxylsyror. FI73678C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8022438A FR2492381A1 (fr) 1980-10-21 1980-10-21 Nouveaux acides aza bicyclo alcane carboxyliques substitues leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR8022438 1980-10-21

Publications (3)

Publication Number Publication Date
FI813279L FI813279L (fi) 1982-04-22
FI73678B FI73678B (fi) 1987-07-31
FI73678C true FI73678C (fi) 1987-11-09

Family

ID=9247120

Family Applications (1)

Application Number Title Priority Date Filing Date
FI813279A FI73678C (fi) 1980-10-21 1981-10-20 Foerfarande foer framstaellning av farmaceutiskt anvaendbara azabicyklo-oktankarboxylsyror.

Country Status (29)

Country Link
US (1) US4397857A (US08063081-20111122-C00044.png)
EP (1) EP0051020B1 (US08063081-20111122-C00044.png)
JP (2) JPS5798281A (US08063081-20111122-C00044.png)
KR (1) KR860001877B1 (US08063081-20111122-C00044.png)
AR (1) AR228621A1 (US08063081-20111122-C00044.png)
AT (1) ATE8892T1 (US08063081-20111122-C00044.png)
AU (1) AU540609B2 (US08063081-20111122-C00044.png)
CA (1) CA1183140A (US08063081-20111122-C00044.png)
DD (1) DD201891A5 (US08063081-20111122-C00044.png)
DE (1) DE3165428D1 (US08063081-20111122-C00044.png)
DK (1) DK162444C (US08063081-20111122-C00044.png)
EG (1) EG15419A (US08063081-20111122-C00044.png)
ES (1) ES506222A0 (US08063081-20111122-C00044.png)
FI (1) FI73678C (US08063081-20111122-C00044.png)
FR (2) FR2492381A1 (US08063081-20111122-C00044.png)
GR (1) GR75389B (US08063081-20111122-C00044.png)
HU (1) HU185058B (US08063081-20111122-C00044.png)
IE (1) IE51823B1 (US08063081-20111122-C00044.png)
IL (1) IL64075A0 (US08063081-20111122-C00044.png)
MA (1) MA19307A1 (US08063081-20111122-C00044.png)
MX (1) MX155032A (US08063081-20111122-C00044.png)
NO (1) NO155098C (US08063081-20111122-C00044.png)
NZ (1) NZ198701A (US08063081-20111122-C00044.png)
OA (1) OA06930A (US08063081-20111122-C00044.png)
PH (1) PH17338A (US08063081-20111122-C00044.png)
PT (1) PT73857B (US08063081-20111122-C00044.png)
SU (1) SU1138022A3 (US08063081-20111122-C00044.png)
YU (1) YU42587B (US08063081-20111122-C00044.png)
ZA (1) ZA817251B (US08063081-20111122-C00044.png)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050800B2 (en) * 1980-10-23 1995-06-07 Schering Corporation Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
IE54551B1 (en) * 1982-01-22 1989-11-22 Ici Plc Amide derivatives
DE3227055A1 (de) * 1982-07-20 1984-01-26 Hoechst Ag, 6230 Frankfurt Neue derivate der 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure als zwischenstufe und verfahren zu deren herstellung
DE3246757A1 (de) * 1982-12-17 1984-06-20 Hoechst Ag, 6230 Frankfurt Neue 2-azabicyclo(2.2.1)heptan-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-azabicyclo(2.2.1)heptan-derivate als zwischenprodukte und verfahren zu deren herstellung
DE3303344A1 (de) 1983-02-02 1984-08-02 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von n-alkylierten aminosaeuren und deren estern
US4693996A (en) * 1985-12-23 1987-09-15 Warner-Lambert Company Method of treating heart failure and medicaments therefor
DE3707911C1 (de) * 1987-03-12 1988-03-31 Texaco Ag Bicyclische Aminkatalysatoren
FR2619813B1 (fr) * 1987-08-28 1991-05-03 Adir Nouveaux derives de l'acide aza - 2 bicyclooctane carboxylique - 3, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2635684A1 (fr) * 1988-08-24 1990-03-02 Adir Utilisation de derives de l'acide aza - 2 bicyclooctane (2.2.2) carboxylique - 3 pour l'obtention de medicaments destines au traitement des maladies consecutives a l'alteration de la paroi vasculaire ainsi qu'aux troubles de la microcirculation
JPH0426348U (US08063081-20111122-C00044.png) * 1990-06-25 1992-03-02
TW197945B (US08063081-20111122-C00044.png) * 1990-11-27 1993-01-11 Hoechst Ag
LT3872B (en) 1993-12-06 1996-04-25 Hoechst Ag Novel peptides and pharmaceutical compositions containing them
FR2746394B1 (fr) 1996-03-20 1998-05-29 Roussel Uclaf Nouveaux composes tricycliques, leur procede de preparation, et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
EP0796855B1 (de) 1996-03-20 2002-02-06 Hoechst Aktiengesellschaft Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
DE19653647A1 (de) 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
DE19821483A1 (de) 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
AU8821301A (en) * 2000-06-28 2002-01-08 Bristol Myers Squibb Co Selective androgen receptor modulators and methods for their identification, design and use
US7001911B2 (en) 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
EP1854798A3 (en) * 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
PL206962B1 (pl) * 2001-12-19 2010-10-29 Bristol Myers Squibb Co Związek heterocykliczny o budowie skondensowanej

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE94175C (US08063081-20111122-C00044.png) *
GB1095105A (en) * 1965-04-12 1967-12-13 Scherico Ltd Novel n-(phenyl-sulfonyl)-isoquinuclidine-carboxamides
US3741973A (en) * 1967-09-11 1973-06-26 Upjohn Co Oxygenated 3-azabicyclo(3.3.1)nonanes
IE52663B1 (en) * 1980-04-02 1988-01-20 Warner Lambert Co Substituted acyl derivatives of octahydro-1h-indole-2-carboxylic acids

Also Published As

Publication number Publication date
JPS6146453B2 (US08063081-20111122-C00044.png) 1986-10-14
DK162444C (da) 1992-03-23
FR2525604A2 (fr) 1983-10-28
KR830007570A (ko) 1983-10-21
YU42587B (en) 1988-10-31
YU245481A (en) 1984-04-30
EP0051020B1 (fr) 1984-08-08
JPS5798281A (en) 1982-06-18
NO155098C (no) 1987-02-11
AR228621A1 (es) 1983-03-30
GR75389B (US08063081-20111122-C00044.png) 1984-07-13
MA19307A1 (fr) 1982-07-01
EG15419A (en) 1986-03-31
PT73857B (fr) 1983-01-25
PT73857A (fr) 1981-11-01
JPS61126025A (ja) 1986-06-13
DD201891A5 (de) 1983-08-17
MX155032A (es) 1988-01-21
ZA817251B (en) 1982-09-29
PH17338A (en) 1984-08-01
CA1183140A (fr) 1985-02-26
IE812460L (en) 1982-04-21
KR860001877B1 (ko) 1986-10-24
ES8301927A1 (es) 1983-01-01
EP0051020A1 (fr) 1982-05-05
FR2492381A1 (fr) 1982-04-23
ES506222A0 (es) 1983-01-01
IE51823B1 (en) 1987-04-01
NO813541L (no) 1982-04-22
FI73678B (fi) 1987-07-31
DE3165428D1 (en) 1984-09-13
FR2492381B1 (US08063081-20111122-C00044.png) 1983-08-12
FR2525604B2 (fr) 1985-06-07
IL64075A0 (en) 1982-01-31
US4397857A (en) 1983-08-09
OA06930A (fr) 1983-05-31
FI813279L (fi) 1982-04-22
DK460181A (da) 1982-04-22
AU7662481A (en) 1982-04-29
ATE8892T1 (de) 1984-08-15
NZ198701A (en) 1984-07-06
SU1138022A3 (ru) 1985-01-30
AU540609B2 (en) 1984-11-29
HU185058B (en) 1984-11-28
JPS6112911B2 (US08063081-20111122-C00044.png) 1986-04-10
DK162444B (da) 1991-10-28
NO155098B (no) 1986-11-03

Similar Documents

Publication Publication Date Title
FI73678C (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara azabicyklo-oktankarboxylsyror.
EP0393457B1 (en) Proteinase inhibitor
KR100805906B1 (ko) 이량체 화합물 및 뉴라미니다제 억제제로서의 용도
ES2128283T3 (es) Profarmacos de inhibidores de trombina.
EP0089637B1 (de) Neue Derivate bicyclischer Aminosäuren, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung sowie neue bicyclische Aminosäuren als Zwischenstufen und Verfahren zu deren Herstellung
SE445352B (sv) Forfarande for framstellning av dipeptider, vilka inhiberar overforing av angiotensin i till angiotensin ii
GB2051779A (en) Esters of acyl-carnitines
US4283418A (en) Guanidinobenzoic acid derivatives and process for their preparation
US4224342A (en) Guanidinobenzoic acid compounds and process for preparing the same
Saari et al. 3-Hydroxy-. alpha.-methyltyrosine progenitors, synthesis and evaluation of some (2-oxo-1, 3-dioxol-4-yl) methyl esters
US5214056A (en) 1,3,2-dioxathiolane oxide derivative
Terinek et al. Synthesis of N‐Acetylglucosamine‐Derived Nagstatin Analogues and Their Evaluation as Glycosidase Inhibitors
EP2199275B1 (en) Inhibitor of ischemic disorders
SK144294A3 (en) Diamine salts of clavulanic acid, method of their preparing, pharmaceutical preparations on their base and using of these salts
HU197878B (en) Process for producing guanidino-benzoic acid esters and pharmaceutical compositions containing them
PT100216B (pt) N-{{4,5-di-hidroxi- e 4,5,8-tri-hidroxi-9,10-di-hidro-9,10-dioxo-2-antracentil} carbonil}-aminoacidos uteis na terapia de afeccoes osteoarticulares, processo para a sua preparacao e composicoes farmaceuticas que os contem
JPH08500597A (ja) 9−クロル−プロスタグランジン−エステルおよび9−クロル−プロスタグランジンアミド並びに医薬品の製造のための該9−クロル−プロスタグランジン−エステルおよび9−クロル−プロスタグランジンアミドの使用
EP1761262B1 (en) Marine compounds with calcium channel blocking properties for the treatment of cognitive or neurodegenerative diseases
EP1307438B1 (en) Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
PL148469B1 (en) Method of obtaining novel derivatives of bicyclo/4.2.0/-octane
HU182322B (en) Process for preparing 1-nitro-9-/hydroxy-alkylamino/-acridines and salts thereof
US4474800A (en) Epoxysuccinyl amino acid derivatives
SE442204B (sv) Fosforamidderivat, forfarande for framstellning av desamma och farmaceutiska kompositioner for behandling av urinvegsstenar och pyelonefrit fororsakat av en urinvegsinfektion av ureasproducerande bakterier
GB1595351A (en) Pharmaceutical compositions containing flavylium compounds
JP3580535B2 (ja) トロンビン阻害剤のプロドラッグ

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: ADIR